GL1X · GenesisL1 explorer

Research workbench

Tmc-95 based biphenyl-ether macrocycles: specific proteasome inhibitors

Analyse Tmc-95 based biphenyl-ether macrocycles: specific proteasome inhibitors in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2GPL
Type
protein
Length
6,368 residues
Chains
28
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proteasome component Y7; Proteasome component Y13; Proteasome component PRE6; Proteasome…
EC
3.4.25.1
UniProt
P23639, P23638, P40303, P32379, P40302, P21242, P21243, P25043, P25451, P22141, P30656, P23724, P30657, P38624
Ligands
BIQ
Pockets
20 · best druggability 0.83

Structure

x-ray diffraction · 14 distinct chains · 35% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, OProteasome component Y7 (EC 3.4.25.1)protein25036% helix, 25% strandP23639
B, PProteasome component Y13 (EC 3.4.25.1)protein24437% helix, 25% strandP23638
C, QProteasome component PRE6 (EC 3.4.25.1)protein24138% helix, 23% strandP40303
D, RProteasome component PUP2 (EC 3.4.25.1)protein24237% helix, 27% strandP32379
E, SProteasome component PRE5 (EC 3.4.25.1)protein23336% helix, 28% strandP40302
F, TProteasome component C1 (EC 3.4.25.1)protein24438% helix, 25% strandP21242
G, UProteasome component C7-alpha (EC 3.4.25.1)protein24339% helix, 23% strandP21243
H, VProteasome component PUP1 (EC 3.4.25.1)protein22229% helix, 34% strandP25043
I, WProteasome component PUP3 (EC 3.4.25.1)protein20432% helix, 33% strandP25451
J, XProteasome component C11 (EC 3.4.25.1)protein19834% helix, 33% strandP22141
K, YProteasome component PRE2 (EC 3.4.25.1)protein21236% helix, 33% strandP30656
L, ZProteasome component C5 (EC 3.4.25.1)protein22228% helix, 31% strandP23724
M, 1Proteasome component PRE4 (EC 3.4.25.1)protein23330% helix, 31% strandP30657
N, 2Proteasome component PRE3 (EC 3.4.25.1)protein19636% helix, 35% strandP38624

Ligands and binding sites

  • BIQ · Benzyl [12-(2-amino-2-oxoethyl)-4-nitro-10,13-dioxo-15-[(propylamino)carbonyl]-2-oxa-11,14-diazatricyclo[15 .2.2.1~3,7~]docosa-1(19),3(22),4,6,17,20-hexaen-9-yl]carbamate · ligand · 2 copies · chains H, I, V, W

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 20 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110050.830.84140empty
210040.830.84138empty
39030.820.84103empty
48210.810.8392empty
511480.800.82113empty

Interfaces

92 interfaces between chains.

  • H–I · 1665 Ų buried · 30 hydrogen bonds · protein-protein
  • V–W · 1651 Ų buried · 30 hydrogen bonds · protein-protein
  • B–C · 1630 Ų buried · 29 hydrogen bonds · protein-protein
  • P–Q · 1575 Ų buried · 22 hydrogen bonds · protein-protein
  • L–V · 1496 Ų buried · 24 hydrogen bonds · protein-protein

Compared structures

  • 2GPL · TMC-95 based biphenyl-ether macrocycles: specific proteasome inhibitors · the same entry in another collection · chain U against U, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.